Safety Study to Evaluate LY3114062 in Participants With Inflammatory Arthritis
Status:
Completed
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to learn more about the safety of LY3114062 and to find out
how well it is tolerated in participants with an inflammatory arthritis. The study will also
investigate how the body processes the drug and how the drug affects inflammatory arthritis.
The study is expected to last about 3 months.